Huntington National Bank Karuna Therapeutics, Inc. Transaction History

Huntington National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$161.01 - $317.85 $9,660 - $19,071	60 Added 0.16%	38,411 $12.2 Million
Q3 2023 Nov 08, 2023	SELL	$164.66 - $218.08 $2,963 - $3,925	-18 Reduced 0.05%	38,351 $6.48 Million
Q2 2023 Aug 11, 2023	BUY	$176.32 - $240.22 $3,173 - $4,323	18 Added 0.05%	38,369 $8.32 Million
Q1 2023 May 10, 2023	BUY	$161.33 - $204.36 $22,586 - $28,610	140 Added 0.37%	38,351 $6.97 Million
Q3 2020 Oct 30, 2020	BUY	$71.31 - $109.74 $2.72 Million - $4.19 Million	38,211 New	38,211 $2.95 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

Stay updated on Huntington National Bank with notifications on news.